Regulation of transforming growth factor-β1 activation and expression in the tissue remodeling involved in chronic rhinosinusitis

ORL

Volumn 74, Issue 3, 2012, Pages 172-178

  Kou, Wei ^a   Hu, Guo Hua ^a   Yao, Hong Bing ^b   Wang, Xiao Qiang ^a   Shen, Yang ^a   Kang, Hong Yong ^a   Hong, Su Ling ^a  

^a CHONGQING MEDICAL UNIVERSITY   (China)

^b CHILDREN S HOSPITAL OF CHONGQING MEDICAL UNIVERSITY   (China)

Author keywords

Chronic rhinosinusitis; Dysregulation; Tissue remodeling; Transforming growth factor 1

Indexed keywords

AROMATIC HYDROCARBON RECEPTOR; LATENT TRANSFORMING GROWTH FACTOR BETA BINDING PROTEIN; TRANSFORMING GROWTH FACTOR BETA1;

CHRONIC INFLAMMATION; CHRONIC RHINITIS; CHRONIC SINUSITIS; DISEASE COURSE; HUMAN; NONHUMAN; NOSE MUCOSA; PARANASAL SINUS; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW; RHINOSINUSITIS; SCANNING ELECTRON MICROSCOPY;

CHRONIC DISEASE; HUMANS; RHINITIS; SIGNAL TRANSDUCTION; SINUSITIS; TRANSFORMING GROWTH FACTOR BETA1;

EID: 84861915603     PISSN: 03011569     EISSN: 14230275     Source Type: Journal    
DOI: 10.1159/000338799     Document Type: Review

References (40)

1. Zang HR, Wang T, Li YC, Zhang SZ, Fan EZ, Han DM: Value of nasal mucosa congestion index in choosing treatment strategies for chronic rhinosinusitis. Acta Otolaryngol 2009;129:1237-1241.
2. Hamilos DL: Chronic rhinosinusitis: epidemiology and medical management. J Allergy Clin Immunol 2011;128:693-707, quiz 08-9.
3. Van Bruaene N, Derycke L, Perez-Novo CA, Gevaert P, Holtappels G, De Ruyck N, et al: TGF-beta signaling and collagen deposition in chronic rhinosinusitis. J Allergy Clin Immunol 2009;124:253-259, 59 e1-2.
4. Li X, Meng J, Qiao X, Liu Y, Liu F, Zhang N, et al: Expression of TGF, matrix metalloproteinases, and tissue inhibitors in Chinese chronic rhinosinusitis. J Allergy Clin Immunol 2010;125:1061-1068.
5. Thiele A, Holzhausen HJ, Riederer A, Knipping S: Mucosal remodeling in chronic rhinosinusitis without nasal polyposis - an ultrastructural evaluation (in German). Laryngorhinootologie 2010;89:352-357.
6. Zhang N, Liu S, Lin P, Li X, van Bruaene N, Zhang J, et al: Remodeling and inflammation in Chinese versus white patients with chronic rhinosinusitis. J Allergy Clin Immunol 2010;125:507, author reply 507-508.
7. Koli K, Saharinen J, Hyytiainen M, Penttinen C, Keski-Oja J: Latency, activation, and binding proteins of TGF-beta. Microsc Res Tech 2001;52:354-362.
8. Santibanez JF, Quintanilla M, Bernabeu C: TGF-beta/TGF-beta receptor system and its role in physiological and pathological conditions. Clin Sci (Lond) 2011;121:233-251.
9. Isogai Z, Ono RN, Ushiro S, Keene DR, Chen Y, Mazzieri R, et al: Latent transforming growth factor beta-binding protein 1 interacts with fibrillin and is a microfibril-associated protein. J Biol Chem 2003;278:2750-2757.
10. Rifkin DB: Latent transforming growth factor-beta (TGF-beta) binding proteins: orchestrators of TGF-beta availability. J Biol Chem 2005;280:7409-7412.
11. Hirschberg A, Jokuti A, Darvas Z, Almay K, Repassy G, Falus A: The pathogenesis of nasal polyposis by immunoglobulin E and interleukin-5 is completed by transforming growth factor-beta1. Laryngoscope 2003;113:120-124.
12. Watelet JB, Claeys C, Perez-Novo C, Gevaert P, Van Cauwenberge P, Bachert C: Transforming growth factor beta1 in nasal remodeling: differences between chronic rhinosinusitis and nasal polyposis. Am J Rhinol 2004;18:267-272.
13. Wipff PJ, Hinz B: Integrins and the activation of latent transforming growth factor beta1 - an intimate relationship. Eur J Cell Biol 2008;87:601-615.
14. Worthington JJ, Klementowicz JE, Travis MA: TGFbeta: a sleeping giant awoken by integrins. Trends Biochem Sci 2011;36:47-54.
15. Jenkins G: The role of proteases in transforming growth factor-beta activation. Int J Biochem Cell Biol 2008;40:1068-1078.
16. Tillie-Leblond I, Pugin J, Marquette CH, Lamblin C, Saulnier F, Brichet A, et al: Balance between proinflammatory cytokines and their inhibitors in bronchial lavage from patients with status asthmaticus. Am J Respir Crit Care Med 1999;159:487-494.
17. Oshita Y, Koga T, Kamimura T, Matsuo K, Rikimaru T, Aizawa H: Increased circulating 92 kDa matrix metalloproteinase (MMP-9) activity in exacerbations of asthma. Thorax 2003;58:757-760.
18. Lee YM, Kim SS, Kim HA, Suh YJ, Lee SK, Nahm DH, et al: Eosinophil inflammation of nasal polyp tissue: relationships with matrix metalloproteinases, tissue inhibitor of metalloproteinase-1, and transforming growth factor-beta1. J Korean Med Sci 2003;18:97-102.
19. Maiuri L, Luciani A, Giardino I, Raia V, Villella VR, D'Apolito M, et al: Tissue transglutaminase activation modulates inflammation in cystic fibrosis via PPARgamma down-regulation. J Immunol 2008;180:7697-7705.
20. Rinia AB, Kostamo K, Ebbens FA, van Drunen CM, Fokkens WJ: Nasal polyposis: a cellular-based approach to answering questions. Allergy 2007;62:348-358.
21. Mu D, Cambier S, Fjellbirkeland L, Baron JL, Munger JS, Kawakatsu H, et al: The integrin alpha(v)beta8 mediates epithelial homeostasis through MT1-MMP-dependent activation of TGF-beta1. J Cell Biol 2002;157:493-507.
22. Munger JS, Huang X, Kawakatsu H, Griffiths MJ, Dalton SL, Wu J, et al: The integrin alpha v beta 6 binds and activates latent TGF beta 1: a mechanism for regulating pulmonary inflammation and fibrosis. Cell 1999;96:319-328.
23. McNulty CA, Symon FA, Wardlaw AJ: Characterization of the integrin and activation steps mediating human eosinophil and neutrophil adhesion to chronically inflamed airway endothelium. Am J Respir Cell Mol Biol 1999;20:1251-1259.
24. Cho JY, Miller M, Baek KJ, Han JW, Nayar J, Lee SY, et al: Inhibition of airway remodeling in IL-5-deficient mice. J Clin Invest 2004;113:551-560.
25. Watelet JB, Bachert C, Claeys C, Van Cauwenberge P: Matrix metalloproteinases MMP-7, MMP-9 and their tissue inhibitor TIMP-1: expression in chronic sinusitis vs nasal polyposis. Allergy 2004;59:54-60.
26. Spinozzi F, de Benedictis D, de Benedictis FM: Apoptosis, airway inflammation and anti-asthma therapy: from immunobiology to clinical application. Pediatr Allergy Immunol 2008;19:287-295.
27. Gomez-Duran A, Ballestar E, Carvajal-Gonzalez JM, Marlowe JL, Puga A, Esteller M, et al: Recruitment of CREB1 and histone deacetylase 2 (HDAC2) to the mouse Ltbp-1 promoter regulates its constitutive expression in a dioxin receptor-dependent manner. J Mol Biol 2008;380:1-16.
28. Walton KL, Makanji Y, Chen J, Wilce MC, Chan KL, Robertson DM, et al: Two distinct regions of latency-associated peptide coordinate stability of the latent transforming growth factor-beta1 complex. J Biol Chem 2010;285:17029-17037.
29. Gomez-Duran A, Carvajal-Gonzalez JM, Mulero-Navarro S, Santiago-Josefat B, Puga A, Fernandez-Salguero PM: Fitting a xenobiotic receptor into cell homeostasis: how the dioxin receptor interacts with TGFbeta signaling. Biochem Pharmacol 2009;77:700-712.
30. Lahvis GP, Lindell SL, Thomas RS, McCuskey RS, Murphy C, Glover E, et al: Portosystemic shunting and persistent fetal vascular structures in aryl hydrocarbon receptor-deficient mice. Proc Natl Acad Sci USA 2000;97:10442-10447.
31. Hsu YC, Kuo WR, Chen YY, Tai CF, Tsai CJ, Wang LF: Increased expression of hypoxia-inducible factor 1alpha in the nasal polyps. Am J Otolaryngol 2007;28:379-383.
32. Meltzer EO, Hamilos DL, Hadley JA, Lanza DC, Marple BF, Nicklas RA, et al: Rhinosinusitis: establishing definitions for clinical research and patient care. Otolaryngol Head Neck Surg 2004;131:S1-62.
33. Fokkens W, Lund V, Mullol J: European position paper on rhinosinusitis and nasal polyps 2007. Rhinol Suppl 2007:1-136.
34. Serpero L, Petecchia L, Sabatini F, Giuliani M, Silvestri M, Di Blasi P, et al: The effect of transforming growth factor (TGF)-beta1 and (TGF)-beta2 on nasal polyp fibroblast activities involved upper airway remodeling: modulation by fluticasone propionate. Immunol Lett 2006; 105: 61-67.
35. Gosepath J, Mann WJ: Current concepts in therapy of chronic rhinosinusitis and nasal polyposis. ORL J Otorhinolaryngol Relat Spec 2005;67:125-136.
36. Luo Q, Chen F, Liu W, Li Z, Xu R, Fan Y, et al: Evaluation of long-term clarithromycin treatment in adult Chinese patients with chronic rhinosinusitis without nasal polyps. ORL J Otorhinolaryngol Relat Spec 2011;73:206-211.
37. Van Bruaene N, Bachert C: Tissue remodeling in chronic rhinosinusitis. Curr Opin Allergy Clin Immunol 2011;11:8-11.
38. Hamilos DL, Leung DY, Huston DP, Kamil A, Wood R, Hamid Q: GM-CSF, IL-5 and RANTES immunoreactivity and mRNA expression in chronic hyperplastic sinusitis with nasal polyposis (NP). Clin Exp Allergy 1998;28:1145-1152.
39. Hori Y, Katoh T, Hirakata M, Joki N, Kaname S, Fukagawa M, et al: Anti-latent TGF-beta binding protein-1 antibody or synthetic oligopeptides inhibit extracellular matrix expression induced by stretch in cultured rat mesangial cells. Kidney Int 1998;53:1616-1625.
40. Flood-Page P, Menzies-Gow A, Phipps S, Ying S, Wangoo A, Ludwig MS, et al: Anti-IL-5 treatment reduces deposition of ECM proteins in the bronchial subepithelial basement membrane of mild atopic asthmatics. J Clin Invest 2003;112:1029-1036.